In September 2023, Parexel and Partex have inked a deal aiming to leverage synthetic intelligence (AI)-driven solutions to speed up drug discovery and advancement for biopharmaceutical customers all over the world and de-hazard the property of their portfolios. The globalization of clinical trials signifies A different crucial driver of your clini